+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
All Ages
All Genders
ID05561205

Study of Repetitive Transcranial Magnetic Stimulation rTMS to Treat Apathy in Alzheimers and Other Neurocognitive Disorders With or Without Methylphenidate Medication

Led by Sunnybrook Health Sciences Centre · Updated on 2026-04-13

10

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Apathy, characterized by lack of interest and enthusiasm, is a common and disabling early symptom in conditions like Alzheimers disease, dementia, mild behavioural impairment, and other neurocognitive disorders. Researchers are evaluating repetitive transcranial magnetic stimulation rTMS, a non-invasive brain stimulation, as a treatment for apathy in people with these conditions. The study also examines rTMS effects in individuals both receiving and not receiving methylphenidate, a medication previously shown to improve apathy. Participants receive one of two treatments rTMS combined with methylphenidate or rTMS alone. Both treatments are being studied to understand their impact on apathy symptoms. This is a non-randomized, single-masked study where participants are assigned to either treatment group. The trial began in February 2023 and is sponsored by Sunnybrook Health Sciences Centre. During the trial, researchers assess apathy using the Neuropsychiatric Inventory-apathy scale after 2 weeks. Care partners who spend significant time with participants will be involved. Participants must have stable medication doses related to cognition or behavior for at least 4 weeks prior. Safety monitoring excludes people with certain medical conditions or current depressive episodes. The study will continue until December 2026.

CONDITIONS

Brief Title

rTMS for Apathy Clinical Trial

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here